NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
24/07/2024
Voltar para busca
Dado oficial do USPTO
TRANSGENE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TRANSGENE
ST13
US500000085917725Classe
1, 5, 42
Pedido
85917725
Registro
4531052
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
24/07/2024
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
29/04/2013
Data de registro
13/05/2014
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/07/2024
Última transação
24/07/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Illkirch-graffenstaden, FR
Examinador
FATHY, DOMINIC
Titulares e representantes
Titulares
Transgene, S.A.
Representantes
Pina Campagna Carter, DeLuca, & Farrell, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in research in the field of chemistry bacteriologyvirologyimmunologymolecular biologygenetic engineeringgene therapy and human and veterinary medicinechemical reagentslytic reagentsbacteriostatic reagentsfungicidal reagentsenzyme reagentsrinsing reagents and cleaning reagents all for use with hematologycytologicalparticulatevirological and chemical analytical automated and semiautomated study and analysis instrumentsmachines and systems used in diagnosticindustrialbiologicalcytology laboratories all for scientific or research use; monoclonal antibodies and antigens for diagnosticscientificresearch use; reagentsdiluents and buffers as packaged in ready-to-use dispensing packages for scientific or research use; cell markers used as reagents for diagnosticscientificresearch use; dyes and stains for microscopic specimen slides and flow cytometry used in diagnostic or scientific research; microspheresfluoroscopes and monodispersed particles for use as standardscalibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biologicalindustrialacademic fields for scientific or research use; whole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnosticscientific or research use; diluentsstandardsstabilizersbuffersreference control compositionsimmersion oilsheath fluids and wetting fluids for scientific and research use; diagnostic laboratory reagents for hemoglobin testing for scientific and research use; reagents for hemoglobin testing for scientific and research use; reagents for use with automatic chemical analysis instruments in biologicalchemicalindustrial and clinical laboratories for scientific or research use; and cell markers for diagnostic and research use
Classe 5
Pharmaceutical preparations for use in treatment of cancercentral nervous system diseasesmultiple sclerosisautoimmune diseases and hypersensitivitiesinfectious diseases and hematological conditions
Classe 42
Research and scientific studies in the fields of chemistrybacteriologygeneticshuman and veterinary medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
24/07/2024
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
24/07/2024
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
24/07/2024
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
24/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/07/2024
PCBM
PETITION TO DIRECTOR WITHDRAWN
15/07/2024
APET
ASSIGNED TO PETITION STAFF
27/06/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/05/2024
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
01/05/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
29/04/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/05/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
30/10/2019
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
30/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/10/2019
ES8R
TEAS SECTION 8 RECEIVED
10/10/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/05/2019
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
13/05/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/04/2014
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/04/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/03/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/03/2014
GNRT
NON-FINAL ACTION E-MAILED
13/03/2014
CNRT
NON-FINAL ACTION WRITTEN
13/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/02/2014
ALIE
ASSIGNED TO LIE
13/02/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/08/2013
GNRT
NON-FINAL ACTION E-MAILED
20/08/2013
CNRT
NON-FINAL ACTION WRITTEN
20/08/2013
DOCK
ASSIGNED TO EXAMINER
15/08/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
07/05/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/05/2013
NWAP
NEW APPLICATION ENTERED
02/05/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TRANSGENE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.